<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Caris-Life-Sciences on Bioecon</title><link>https://en.bioecon.ru/companies/caris-life-sciences/</link><description>Recent content in Caris-Life-Sciences on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 17:49:19 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/caris-life-sciences/index.xml" rel="self" type="application/rss+xml"/><item><title>Multi-omics diagnostic panels for precision oncology</title><link>https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/</guid><description>Integrative genomic, transcriptomic and proteomic oncology profiling platforms that combine multiple molecular data layers into a single treatment-matching report, broader than a single drug-label companion diagnostic: Tempus AI and Caris Life Sciences in the US, Sophia Genetics in Switzerland, Geneseeq Technology in China, and 1cell.ai in India.</description></item></channel></rss>